Banque Transatlantique Sa Bioventus Inc. Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
A detailed history of Banque Transatlantique Sa transactions in Bioventus Inc. stock. As of the latest transaction made, Banque Transatlantique Sa holds 360 shares of BVS stock, worth $2,350. This represents 0.0% of its overall portfolio holdings.
Number of Shares
360Holding current value
$2,350% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BVS
# of Institutions
154Shares Held
47.9MCall Options Held
77.9KPut Options Held
39.3K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$85 Million34.4% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$45.3 Million27.92% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.13MShares$26.9 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$16.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$15.5 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $403M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...